1. Home
  2. GBIO vs EBON Comparison

GBIO vs EBON Comparison

Compare GBIO & EBON Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • GBIO
  • EBON
  • Stock Information
  • Founded
  • GBIO 2016
  • EBON 2010
  • Country
  • GBIO United States
  • EBON China
  • Employees
  • GBIO N/A
  • EBON N/A
  • Industry
  • GBIO Biotechnology: Pharmaceutical Preparations
  • EBON Semiconductors
  • Sector
  • GBIO Health Care
  • EBON Technology
  • Exchange
  • GBIO Nasdaq
  • EBON Nasdaq
  • Market Cap
  • GBIO 29.2M
  • EBON 25.3M
  • IPO Year
  • GBIO 2020
  • EBON 2020
  • Fundamental
  • Price
  • GBIO $0.42
  • EBON $4.94
  • Analyst Decision
  • GBIO Strong Buy
  • EBON
  • Analyst Count
  • GBIO 4
  • EBON 0
  • Target Price
  • GBIO $7.33
  • EBON N/A
  • AVG Volume (30 Days)
  • GBIO 1.1M
  • EBON 31.3K
  • Earning Date
  • GBIO 08-06-2025
  • EBON 08-22-2025
  • Dividend Yield
  • GBIO N/A
  • EBON N/A
  • EPS Growth
  • GBIO N/A
  • EBON N/A
  • EPS
  • GBIO N/A
  • EBON N/A
  • Revenue
  • GBIO $24,556,000.00
  • EBON $5,868,771.00
  • Revenue This Year
  • GBIO N/A
  • EBON N/A
  • Revenue Next Year
  • GBIO N/A
  • EBON N/A
  • P/E Ratio
  • GBIO N/A
  • EBON N/A
  • Revenue Growth
  • GBIO 146.47
  • EBON 20.88
  • 52 Week Low
  • GBIO $0.30
  • EBON $3.00
  • 52 Week High
  • GBIO $3.65
  • EBON $10.94
  • Technical
  • Relative Strength Index (RSI)
  • GBIO 57.35
  • EBON 75.89
  • Support Level
  • GBIO $0.32
  • EBON $3.28
  • Resistance Level
  • GBIO $0.36
  • EBON $3.49
  • Average True Range (ATR)
  • GBIO 0.03
  • EBON 0.31
  • MACD
  • GBIO 0.01
  • EBON 0.09
  • Stochastic Oscillator
  • GBIO 100.00
  • EBON 95.54

About GBIO Generation Bio Co.

Generation Bio Co is a genetics medicine company focused on creating gene therapies to provide durable and redosable treatments for patients suffering from rare and untreated diseases. The company focuses on liver and retina-related diseases. It is developing two distinct and complementary platforms that It believes will enable highly differentiated therapeutic applications. Its first platform is a potent, highly selective ctLNP delivery system for nucleic acids, which is designed to avoid off-target clearance by the liver and spleen, enabling ctLNPs to persist in systemic circulation and allowing for highly selective and potent ligand-driven targeting to specific tissues and cell types. Its second platform is its novel iqDNA, which is an optimized variant of its ceDNA.

About EBON Ebang International Holdings Inc.

Ebang International Holdings Inc is a blockchain technology and Fintech company, that has ASIC chip design capability. Its business is ASIC chip design and Telecommunication. It operates in a single segment selling bitcoin mining machines and related accessories, telecommunication products, providing cryptocurrency exchange services, management and maintenance services, and cross-border payment and foreign exchange services and rental services. Its geographic regions are Mainland China, and Australia.

Share on Social Networks: